1. Schneider W, Knahr K. Total hip replacement in younger patients: survival rate after avascular necrosis of the femoral head. Acta Orthop Scand 2004;75:142-146.
2. Hungerford DS. Treatment of osteonecrosis of the femoral head: everything's new. J Arthroplasty 2007;22:91-94.
3. Shibatani M, Fujioka M, Arai Y, et al. Degree of corticosteroid treatment within the first 2 months of renal transplantation has a strong influence on the incidence of osteonecrosis of the femoral head. Acta Orthop 2008;79:631-636.
4. Arlet J. Nontraumatic avascular necrosis of the femoral head. Past, present, and future. Clin Orthop Relat Res 1992;(277):12-21.
6. Hungerford DS. Osteonecrosis: avoiding total hip arthroplasty. J Arthroplasty 2002;17(4 Suppl 1):121-124.
7. Kang JS, Park S, Song JH, et al. Prevalence of osteonecrosis of the femoral head: a nationwide epidemiologic analysis in Korea. J Arthroplasty 2009;24:1178-1183.
9. Li D, Yang Z, Wei Z, et al. Efficacy of bisphosphonates in the treatment of femoral head osteonecrosis: A PRISMA-compliant meta-analysis of animal studies and clinical trials. Sci Rep 2018;8:1450
10. Koo KH, Jeong ST, Jones JP Jr. Borderline necrosis of the femoral head. Clin Orthop Relat Res 1999;(358):158-165.
11. Glueck CJ, Freiberg RA, Sieve L, et al. Enoxaparin prevents progression of stages I and II osteonecrosis of the hip. Clin Orthop Relat Res 2005;(435):164-170.
12. Glueck CJ, Freiberg RA, Wissman R, et al. Long term anticoagulation (4-16 years) stops progression of idiopathic hip osteonecrosis associated with familial thrombophilia. Adv Orthop 2015;2015:138382.
13. Chotanaphuti T, Thongprasert S, Laoruengthana A. Low molecular weight heparin prevents the progression of precollapse osteonecrosis of the hip. J Med Assoc Thai 2013;96:1326-1330.
14. Pritchett JW. Statin therapy decreases the risk of osteonecrosis in patients receiving steroids. Clin Orthop Relat Res 2001;(386):173-178.
15. Pengde K, Fuxing P, Bin S, et al. Lovastatin inhibits adipogenesis and prevents osteonecrosis in steroid-treated rabbits. Joint Bone Spine 2008;75:696-701.
18. Lai KA, Shen WJ, Yang CY, et al. The use of alendronate to prevent early collapse of the femoral head in patients with nontraumatic osteonecrosis. A randomized clinical study. J Bone Joint Surg Am 2005;87:2155-2159.
20. Nishii T, Sugano N, Miki H, et al. Does alendronate prevent collapse in osteonecrosis of the femoral head? Clin Orthop Relat Res 2006;443:273-279.
21. Chen CH, Chang JK, Lai KA, et al. Alendronate in the prevention of collapse of the femoral head in nontraumatic osteonecrosis: a two-year multicenter, prospective, randomized, double-blind, placebo-controlled study. Arthritis Rheum 2012;64:1572-1578.
22. Lee YK, Ha YC, Cho YJ, et al. Does zoledronate prevent femoral head collapse from osteonecrosis? A prospective, randomized, open-label, multicenter study. J Bone Joint Surg Am 2015;97:1142-1148.
23. Pazianas M, Abrahamsen B. Safety of bisphosphonates. Bone 2011;49:103-110.
26. Pountos I, Giannoudis PV. The role of Iloprost on bone edema and osteonecrosis: safety and clinical results. Expert Opin Drug Saf 2018;17:225-233.
28. Sugano N, Atsumi T, Ohzono K, et al. The 2001 revised criteria for diagnosis, classification, and staging of idiopathic osteonecrosis of the femoral head. J Orthop Sci 2002;7:601-605.
29. Koo KH, Ahn IO, Kim R, et al. Bone marrow edema and associated pain in early stage osteonecrosis of the femoral head: prospective study with serial MR images. Radiology 1999;213:715-722.
30. Ha YC, Jung WH, Kim JR, et al. Prediction of collapse in femoral head osteonecrosis: a modified Kerboul method with use of magnetic resonance images. J Bone Joint Surg Am 2006;88(Suppl 3):35-40.
31. Steinberg ME, Hayken GD, Steinberg DR. A quantitative system for staging avascular necrosis. J Bone Joint Surg Br 1995;77:34-41.